Alessio D. Nahmad

Frequent aneuploidy in primary human T cells after CRISPR–Cas9 cleavage

Alessio D. Nahmad, Eli Reuveni, Ella Goldschmidt et al. · Nature Biotechnology · 2022 · 198 citations · Full text

Immune Cell Development, Genetics, Immunology +8

Engineered B cells expressing an anti-HIV antibody enable memory retention, isotype switching and clonal expansion

Alessio D. Nahmad, Yuval Raviv, Miriam Horovitz‐Fried et al. · Nature Communications · 2020 · 83 citations · Full text

In vivo engineered B cells secrete high titers of broadly neutralizing anti-HIV antibodies in mice

Alessio D. Nahmad, Cícera R. Lazzarotto, Natalie Zelikson et al. · Nature Biotechnology · 2022 · 83 citations · Full text

Human Retrovirus, Humoral Response, Immunology +8

MCP-1/CCR2 axis inhibition sensitizes the brain microenvironment against melanoma brain metastasis progression

Sabina Pozzi, Anna Scomparin, Dikla Ben‐Shushan et al. · JCI Insight · 2022 · 28 citations · Full text

Immunology, Mcp-1/ccr2 Axis Inhibition, Brain Microenvironment +16

Frequent Aneuploidy in Primary Human T Cells Following CRISPR-Cas9 cleavage

Alessio D. Nahmad, Eli Reuveni, Ella Goldschmidt et al. · 2021 · 10 citations · Full text